Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mohamed S. Mohamed Ahmed, Ahmed M. Abdelfattah & Ahmed A. M. Ahmed. (2023) Synthesis of novel benzo[6,7]cyclohepta[1,2-b]thieno[3,2-e]pyridines and their bis-analogues linked to different spacers: Approach to a new ring system. Synthetic Communications 53:20, pages 1701-1712.
Read now
Read now
Dayong Zheng, Xing Chang, Yang Liu, Jingwen Xu, Wenfeng Gou, Zengqiang Li, Daiying Zuo, Weige Zhang & Yingliang Wu. (2019) 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines. Cancer Biology & Therapy 20:4, pages 513-523.
Read now
Read now
Haider Behbehani, Kamal M. Dawood & Thoraya A. Farghaly. (2018) Biological evaluation of benzosuberones. Expert Opinion on Therapeutic Patents 28:1, pages 5-29.
Read now
Read now
Bart J Crielaard, Steffen van der Wal, Twan Lammers, Huong Thu Le, Wim E Hennink, Raymond M Schiffelers, Gert Storm & Marcel HAM Fens. (2011) A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy. International Journal of Nanomedicine 6, pages 2697-2703.
Read now
Read now
Jie Zhou, Yi Zhang, Yi-Wen Cui, Zhan-Mei Li, Hong-Rui Song, Jin-Hua Dong, Xiao-Guang Chen & Bai-Ling Xu. (2011) Synthesis and cytotoxic evaluation of N-(4-methoxy-1H-benzo[d]imidazol-7-yl)-arylsulfonamide and N-aryl-(4-methoxy-1H-benzo[d]imidazol)-7-sulfonamide analogs of combretastatin A-4. Journal of Asian Natural Products Research 13:4, pages 330-340.
Read now
Read now
Marcel HAM Fens, Gert Storm & Raymond M Schiffelers. (2010) Tumor vasculature as target for therapeutic intervention. Expert Opinion on Investigational Drugs 19:11, pages 1321-1338.
Read now
Read now
Articles from other publishers (61)
Franziska Reipsch, Bernhard Biersack, Henrike Lucas, Rainer Schobert & Thomas Mueller. (2021) Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models. International Journal of Molecular Sciences 22:23, pages 13082.
Crossref
Crossref
Linda Wordeman & Juan Jesus Vicente. (2021) Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles. Cancers 13:22, pages 5650.
Crossref
Crossref
Mei Yang, Yanhong Su, Zhiqiang Wang, Danyu Du, Shihui Wei, Zhengguang Liao, Qian Zhang, Liwen Zhao, Xian Zhang, Luwei Han, Jingwei Jiang, Meixiao Zhan, Li Sun, Shengtao Yuan & Zhiling Zhou. (2021) C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma. Biochemical Pharmacology 190, pages 114641.
Crossref
Crossref
Olagoke Zacchaeus Olatunde, Jianping Yong & Canzhong Lu. (2021) The Progress of the Anticancer Agents Related to the Microtubules Target. Mini-Reviews in Medicinal Chemistry 20:20, pages 2165-2192.
Crossref
Crossref
Jhansi Nathan & Rajaretinam Rajesh Kannan. (2020) Antiangiogenic molecules from marine actinomycetes and the importance of using zebrafish model in cancer research. Heliyon 6:12, pages e05662.
Crossref
Crossref
Krzysztof M. Mrozik, Chee M. Cheong, Duncan R. Hewett, Jacqueline E. Noll, Khatora S. Opperman, Alaknanda Adwal, Darryl L. Russell, Orest W. Blaschuk, Kate Vandyke & Andrew C. W. Zannettino. (2020) LCRF‐0006, a small molecule mimetic of the N‐cadherin antagonist peptide ADH‐1, synergistically increases multiple myeloma response to bortezomib. FASEB BioAdvances 2:6, pages 339-353.
Crossref
Crossref
Vladimír Čermák, Vojtěch Dostál, Michael Jelínek, Lenka Libusová, Jan Kovář, Daniel Rösel & Jan Brábek. (2020) Microtubule-targeting agents and their impact on cancer treatment. European Journal of Cell Biology 99:4, pages 151075.
Crossref
Crossref
Gustav Steinemann, Alexandra Dittmer, Jacob Schmidt, David Josuttis, Michael Fähling, Bernhard Biersack, Nicola Beindorff, Eva Jolante Koziolek, Rainer Schobert, Winfried Brenner, Thomas Müller, Bianca Nitzsche & Michael Höpfner. (2019) Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer. Molecular Oncology 13:12, pages 2679-2696.
Crossref
Crossref
Jason H. Gill, Kimberly L. Rockley, Carol De Santis & Asma K. Mohamed. (2019) Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics. Pharmacology & Therapeutics 202, pages 18-31.
Crossref
Crossref
Haichan Niu, Tracy E. Strecker, Jeni L. Gerberich, James W. CampbellIIIIII, Debabrata Saha, Deboprosad Mondal, Ernest Hamel, David J. Chaplin, Ralph P. Mason, Mary Lynn Trawick & Kevin G. Pinney. (2019) Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization. Journal of Medicinal Chemistry 62:11, pages 5594-5615.
Crossref
Crossref
Alba Vicente‐Blázquez, Myriam González, Raquel Álvarez, Sara del Mazo, Manuel Medarde & Rafael Peláez. (2018) Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target. Medicinal Research Reviews 39:3, pages 775-830.
Crossref
Crossref
Andrew W. Brown, Toby Holmes, Matthew Fisher, Gillian M. Tozer, Joseph P. A. Harrity & Chryso Kanthou. (2018) Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy. ChemMedChem 13:24, pages 2618-2626.
Crossref
Crossref
Rasha Z. Batran, Asmaa F. Kassem, Eman M.H. Abbas, Samia A. Elseginy & Marwa M. Mounier. (2018) Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells. Bioorganic & Medicinal Chemistry 26:12, pages 3474-3490.
Crossref
Crossref
Arpita Kulshrestha, Gajendra K. Katara, Safaa A. Ibrahim, Renukadevi Patil, Shivaputra A. Patil & Kenneth D. Beaman. (2017) Microtubule inhibitor, SP-6-27 inhibits angiogenesis and induces apoptosis in ovarian cancer cells. Oncotarget 8:40, pages 67017-67028.
Crossref
Crossref
Jhansi Rani Nathan, Ganesh Lakshmanan, Felicia Mary Michael, Prakash Seppan & Malathi Ragunathan. (2016) Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline—A study using zebrafish model. Biomedicine & Pharmacotherapy 84, pages 1406-1418.
Crossref
Crossref
Andrew W. BrownMatthew FisherGillian M. TozerChryso KanthouJoseph P. A. Harrity. (2016) Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4. Journal of Medicinal Chemistry 59:20, pages 9473-9488.
Crossref
Crossref
Katharina Mahal, Bernhard Biersack, Sebastian Schruefer, Marcus Resch, Ralf Ficner, Rainer Schobert & Thomas Mueller. (2016) Combretastatin A-4 derived 5-(1-methyl-4-phenyl-imidazol-5-yl)indoles with superior cytotoxic and anti-vascular effects on chemoresistant cancer cells and tumors. European Journal of Medicinal Chemistry 118, pages 9-20.
Crossref
Crossref
Raphael C. Bosse, Briana Wasserstrom, Amy Meacham, Elizabeth Wise, Leylah Drusbosky, Glenn A. Walter, David J. Chaplin, Dietmar W. Siemann, Daniel L. Purich & Christopher R. Cogle. (2016) Chemosensitizing AML cells by targeting bone marrow endothelial cells. Experimental Hematology 44:5, pages 363-377.e5.
Crossref
Crossref
Laxman Devkota, Chen-Ming Lin, Tracy E. Strecker, Yifan Wang, Justin K. Tidmore, Zhi Chen, Rajsekhar Guddneppanavar, Christopher J. Jelinek, Ramona Lopez, Li Liu, Ernest Hamel, Ralph P. Mason, David J. Chaplin, Mary Lynn Trawick & Kevin G. Pinney. (2016) Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents. Bioorganic & Medicinal Chemistry 24:5, pages 938-956.
Crossref
Crossref
Surendra R. Punganuru, Hanumantha Rao Madala, Sanjay N. Venugopal, Ramakrishna Samala, Constantinos Mikelis & Kalkunte S. Srivenugopal. (2016) Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties. European Journal of Medicinal Chemistry 107, pages 233-244.
Crossref
Crossref
Tracy E. Strecker, Samuel O. Odutola, Ramona Lopez, Morgan S. Cooper, Justin K. Tidmore, Amanda K. Charlton-Sevcik, Li Li, Matthew T. MacDonough, Mallinath B. Hadimani, Anjan Ghatak, Li Liu, David J. Chaplin, Ralph P. Mason, Kevin G. Pinney & Mary Lynn Trawick. (2015) The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts. Cancer Letters 369:1, pages 229-241.
Crossref
Crossref
Christine A. Herdman, Laxman Devkota, Chen-Ming Lin, Haichan Niu, Tracy E. Strecker, Ramona Lopez, Li Liu, Clinton S. George, Rajendra P. Tanpure, Ernest Hamel, David J. Chaplin, Ralph P. Mason, Mary Lynn Trawick & Kevin G. Pinney. (2015) Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization. Bioorganic & Medicinal Chemistry 23:24, pages 7497-7520.
Crossref
Crossref
Katharina Mahal, Aamir Ahmad, Seema Sethi, Marcus Resch, Ralf Ficner, Fazlul H. Sarkar, Rainer Schobert & Bernhard Biersack. (2015) Role of JNK and NF-κB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cells. Cellular Oncology 38:6, pages 463-478.
Crossref
Crossref
Katharina Mahal, Bernhard Biersack, Henrike Caysa, Rainer Schobert & Thomas Mueller. (2015) Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisation. Investigational New Drugs 33:3, pages 541-554.
Crossref
Crossref
Arvind S. Negi, Yashveer Gautam, Sarfaraz Alam, Debabrata Chanda, Suaib Luqman, Jayanta Sarkar, Feroz Khan & Rituraj Konwar. (2015) Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment. Bioorganic & Medicinal Chemistry 23:3, pages 373-389.
Crossref
Crossref
L J Williams, D Mukherjee, M Fisher, C C Reyes-Aldasoro, S Akerman, C Kanthou & G M Tozer. (2014)
An
in vivo
role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-
O
-phosphate
. British Journal of Pharmacology 171:21, pages 4902-4913.
Crossref
Crossref
Katharina Mahal, Marcus Resch, Ralf Ficner, Rainer Schobert, Bernhard Biersack & Thomas Mueller. (2014) Effects of the Tumor-Vasculature-Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels. ChemMedChem 9:4, pages 847-854.
Crossref
Crossref
Rajendra P. Tanpure, Clinton S. George, Tracy E. Strecker, Laxman Devkota, Justin K. Tidmore, Chen-Ming Lin, Christine A. Herdman, Matthew T. MacDonough, Madhavi Sriram, David J. Chaplin, Mary Lynn Trawick & Kevin G. Pinney. (2013) Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents. Bioorganic & Medicinal Chemistry 21:24, pages 8019-8032.
Crossref
Crossref
Matthew T. MacDonough, Tracy E. Strecker, Ernest Hamel, John J. Hall, David J. Chaplin, Mary Lynn Trawick & Kevin G. Pinney. (2013) Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3′-hydroxy-4′-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006). Bioorganic & Medicinal Chemistry 21:21, pages 6831-6843.
Crossref
Crossref
Jie Zhou, Jing Jin, Yi Zhang, Yuwen Yin, Xiaoguang Chen & Bailing Xu. (2013) Synthesis and antiproliferative evaluation of novel benzoimidazole-contained oxazole-bridged analogs of combretastatin A-4. European Journal of Medicinal Chemistry 68, pages 222-232.
Crossref
Crossref
Jenny Seligmann & Chris Twelves. (2013) Tubulin: an example of targeted chemotherapy. Future Medicinal Chemistry 5:3, pages 339-352.
Crossref
Crossref
B J Passer, T Cheema, S Wu, C-l Wu, S D Rabkin & R L Martuza. (2012) Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models. Cancer Gene Therapy 20:1, pages 17-24.
Crossref
Crossref
Suikinai Nobre Santos, Faustos Klabund Ferraris, Ana Olivia de Souza, Maria das Graças Henriques & Itamar Soares Melo. (2012) Endophytic fungi from Combretum leprosum with potential anticancer and antifungal activity. Symbiosis 58:1-3, pages 109-117.
Crossref
Crossref
Núria Mur Blanch, Guy G. Chabot, Lionel Quentin, Daniel Scherman, Stéphane Bourg & Daniel Dauzonne. (2012) In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4. European Journal of Medicinal Chemistry 54, pages 22-32.
Crossref
Crossref
Mohamed Abdel-Aziz, Omar M. Aly, Sabine S. Khan, Kamalika Mukherjee & Susan Bane. (2012) Synthesis, Cytotoxic Properties and Tubulin Polymerization Inhibitory Activity of Novel 2-Pyrazoline Derivatives. Archiv der Pharmazie 345:7, pages 535-548.
Crossref
Crossref
A.P. Prakasham, A.K. Saxena, Suaib Luqman, Debabrata Chanda, Tandeep Kaur, Atul Gupta, D.K. Yadav, C.S. Chanotiya, Karuna Shanker, F. Khan & Arvind S. Negi. (2012) Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization. Bioorganic & Medicinal Chemistry 20:9, pages 3049-3057.
Crossref
Crossref
Bart J. Crielaard, Steffen van der Wal, Huong Thu Le, Aloïs T.L. Bode, Twan Lammers, Wim E. Hennink, Raymond M. Schiffelers, Marcel H.A.M. Fens & Gert Storm. (2012) Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics. European Journal of Pharmaceutical Sciences 45:4, pages 429-435.
Crossref
Crossref
Charles Swanton & Stephen R. D. JohnstonDavid Miles. 2011. Handbook of Metastatic Breast Cancer. Handbook of Metastatic Breast Cancer
101
119
.
Sarah Jane Lunt, Simon Akerman, Sally A. Hill, Matthew Fisher, Victoria J. Wright, Constantino C. Reyes‐Aldasoro, Gillian M. Tozer & Chryso Kanthou. (2011) Vascular effects dominate solid tumor response to treatment with combretastatin A‐4‐phosphate. International Journal of Cancer 129:8, pages 1979-1989.
Crossref
Crossref
David Cragg, Gordon Kingston & David NewmanKevin Pinney, George Pettit, Mary Trawick, Christopher Jelinek & David Chaplin. 2011. Anticancer Agents from Natural Products, Second Edition. Anticancer Agents from Natural Products, Second Edition
27
64
.
Corrado TringaliCarmela Spatafora & Corrado Tringali. 2011. Bioactive Compounds from Natural Sources, Second Edition. Bioactive Compounds from Natural Sources, Second Edition
299
338
.
Bernard L. Flynn, Gurmit S. Gill, Damian W. Grobelny, Jason H. Chaplin, Dharam Paul, Annabell F. Leske, Tina C. Lavranos, David K. Chalmers, Susan A. Charman, Edmund Kostewicz, David M. Shackleford, Julia Morizzi, Ernest Hamel, M. Katherine Jung & Gabriel Kremmidiotis. (2011)
Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[
b
]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties
. Journal of Medicinal Chemistry 54:17, pages 6014-6027.
Crossref
Crossref
Rajendra P. Tanpure, Benson L. Nguyen, Tracy E. Strecker, Savannah Aguirre, Suman Sharma, David J. Chaplin, Bronwyn G. Siim, Ernest Hamel, John W. LippertIIIIII, George R. Pettit, Mary Lynn Trawick & Kevin G. Pinney. (2011) Regioselective Synthesis of Water-Soluble Monophosphate Derivatives of Combretastatin A-1. Journal of Natural Products 74:7, pages 1568-1574.
Crossref
Crossref
Sébastien Combes, Pascale Barbier, Soazig Douillard, Anne McLeer-Florin, Véronique Bourgarel-Rey, Jean-Thomas Pierson, Alexey Yu. Fedorov, Jean-Pierre Finet, Jean Boutonnat & Vincent Peyrot. (2011) Synthesis and Biological Evaluation of 4-Arylcoumarin Analogues of Combretastatins. Part 2. Journal of Medicinal Chemistry 54:9, pages 3153-3162.
Crossref
Crossref
Edina Komlodi-Pasztor, Dan Sackett, Julia Wilkerson & Tito Fojo. (2011) Mitosis is not a key target of microtubule agents in patient tumors. Nature Reviews Clinical Oncology 8:4, pages 244-250.
Crossref
Crossref
Eddy Pasquier, Snega Sinnappan, Marcia A. Munoz & Maria Kavallaris. (2010) ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties. Molecular Cancer Therapeutics 9:5, pages 1408-1418.
Crossref
Crossref
Bojan Burja, Tamara Čimbora-Zovko, Sanja Tomić, Tihana Jelušić, Marijan Kočevar, Slovenko Polanc & Maja Osmak. (2010) Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies. Bioorganic & Medicinal Chemistry 18:7, pages 2375-2387.
Crossref
Crossref
Deepa Alex, Emilia Conceição Leong, Zai‐Jun Zhang, Gloria Tse Ho Yan, Shuk‐Han Cheng, Chi‐Weng Leong, Zhen‐Hua Li, Kai‐Heng Lam, Shun‐Wan Chan & Simon Ming‐Yuen Lee. (2009)
Resveratrol derivative,
trans
‐3,5,4′‐trimethoxystilbene, exerts antiangiogenic and vascular‐disrupting effects in zebrafish through the downregulation of
VEGFR2
and cell‐cycle modulation
. Journal of Cellular Biochemistry 109:2, pages 339-346.
Crossref
Crossref
Christopher J. Burns, Emmanuelle Fantino, Ian D. Phillips, Stephen Su, Michael F. Harte, Patricia E. Bukczynska, Mark Frazzetto, Max Joffe, Irma Kruszelnicki, Bing Wang, Yue Wang, Neil Wilson, Rodney J. Dilley, Soo S. Wan, Susan A. Charman, David M. Shackleford, Rosa Fida, Cathy Malcontenti-Wilson & Andrew F. Wilks. (2009)
CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity
in vitro
and
in vivo
. Molecular Cancer Therapeutics 8:11, pages 3036-3045.
Crossref
Crossref
Sylvie Ducki, David Rennison, Meiko Woo, Alexander Kendall, Jérémie Fournier Dit Chabert, Alan T. McGown & Nicholas J. Lawrence. (2009) Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity. Bioorganic & Medicinal Chemistry 17:22, pages 7698-7710.
Crossref
Crossref
Christopher J. Burns, Michael F. Harte, Xianyong Bu, Emmanuelle Fantino, Max Joffe, Harrison Sikanyika, Stephen Su, C. Elisabet Tranberg, Neil Wilson, Susan A. Charman, David M. Shackleford & Andrew F. Wilks. (2009) Discovery of CYT997: a structurally novel orally active microtubule targeting agent. Bioorganic & Medicinal Chemistry Letters 19:16, pages 4639-4642.
Crossref
Crossref
Yanping Luo, Vincent P. Hradil, David J. Frost, Saul H. Rosenberg, Gary B. Gordon, Sherry J. Morgan, Gerard D. Gagne, Bryan F. Cox, Stephen K. Tahir & Gerard B. Fox. (2009) ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature. Anti-Cancer Drugs 20:6, pages 483-492.
Crossref
Crossref
Chryso Kanthou & Gillian M. Tozer. (2009) Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies. International Journal of Experimental Pathology 90:3, pages 284-294.
Crossref
Crossref
April L. Risinger, Francis J. Giles & Susan L. Mooberry. (2009) Microtubule dynamics as a target in oncology. Cancer Treatment Reviews 35:3, pages 255-261.
Crossref
Crossref
Anupama Shirali, Madhavi Sriram, John J. Hall, Benson L. Nguyen, Rajsekhar Guddneppanavar, Mallinath B. Hadimani, J. Freeland Ackley, Rogelio Siles, Christopher J. Jelinek, Phyllis Arthasery, Rodney C. Brown, Victor Leon Murrell, Austin McMordie, Suman Sharma, David J. Chaplin & Kevin G. Pinney. (2009) Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 (CA1) and Its Corresponding Prodrug CA1P. Journal of Natural Products 72:3, pages 414-421.
Crossref
Crossref
David G. I. Kingston. (2009) Tubulin-Interactive Natural Products as Anticancer Agents. Journal of Natural Products 72:3, pages 507-515.
Crossref
Crossref
Jennifer H.E. Baker, Jeffrey Lam, Alaistair H. Kyle, Jonathan Sy, Thomas Oliver, Steven J. Co, Wieslawa H. Dragowska, Euan Ramsay, Malathi Anantha, Thomas J. Ruth, Michael J. Adam, Andrew Yung, Piotr Kozlowski, Andrew I. Minchinton, Sylvia S.W. Ng, Marcel B. Bally & Donald T.T. Yapp. (2008) Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin. Clinical Cancer Research 14:22, pages 7260-7271.
Crossref
Crossref
G M Tozer, C Kanthou, G Lewis, V E Prise, B Vojnovic & S A Hill. (2008) Tumour vascular disrupting agents: combating treatment resistance. The British Journal of Radiology 81:special_issue_1, pages S12-S20.
Crossref
Crossref
Madhavi Sriram, John J. Hall, Nathan C. Grohmann, Tracy E. Strecker, Taylor Wootton, Andreas Franken, Mary Lynn Trawick & Kevin G. Pinney. (2008) Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy. Bioorganic & Medicinal Chemistry 16:17, pages 8161-8171.
Crossref
Crossref
Nancy Ty, Grégory Dupeyre, Guy G. Chabot, Johanne Seguin, François Tillequin, Daniel Scherman, Sylvie Michel & Xavier Cachet. (2008) Synthesis and biological evaluation of new disubstituted analogues of 6-methoxy-3-(3′,4′,5′-trimethoxybenzoyl)-1H-indole (BPR0L075), as potential antivascular agents. Bioorganic & Medicinal Chemistry 16:15, pages 7494-7503.
Crossref
Crossref
Chryso Kanthou & Gillian M. Tozer. (2007) Selective destruction of the tumour vasculature by targeting the endothelial cytoskeleton. Drug Discovery Today: Therapeutic Strategies 4:4, pages 237-243.
Crossref
Crossref